These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 26506247)

  • 1. The C34 Peptide Fusion Inhibitor Binds to the Six-Helix Bundle Core Domain of HIV-1 gp41 by Displacement of the C-Terminal Helical Repeat Region.
    Louis JM; Baber JL; Clore GM
    Biochemistry; 2015 Nov; 54(45):6796-805. PubMed ID: 26506247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Tryptophan-Rich Motif of HIV-1 gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of gp41 and Its Inhibitors.
    Zhu Y; Ding X; Yu D; Chong H; He Y
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 variants with a single-point mutation in the gp41 pocket region exhibiting different susceptibility to HIV fusion inhibitors with pocket- or membrane-binding domain.
    Lu L; Tong P; Yu X; Pan C; Zou P; Chen YH; Jiang S
    Biochim Biophys Acta; 2012 Dec; 1818(12):2950-7. PubMed ID: 22867851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
    Gallo SA; Sackett K; Rawat SS; Shai Y; Blumenthal R
    J Mol Biol; 2004 Jun; 340(1):9-14. PubMed ID: 15184018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conserved salt bridge between the N- and C-terminal heptad repeat regions of the human immunodeficiency virus type 1 gp41 core structure is critical for virus entry and inhibition.
    He Y; Liu S; Li J; Lu H; Qi Z; Liu Z; Debnath AK; Jiang S
    J Virol; 2008 Nov; 82(22):11129-39. PubMed ID: 18768964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved residue Lys574 in the cavity of HIV-1 Gp41 coiled-coil domain is critical for six-helix bundle stability and virus entry.
    He Y; Liu S; Jing W; Lu H; Cai D; Chin DJ; Debnath AK; Kirchhoff F; Jiang S
    J Biol Chem; 2007 Aug; 282(35):25631-9. PubMed ID: 17616522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation.
    Rabenstein M; Shin YK
    Biochemistry; 1995 Oct; 34(41):13390-7. PubMed ID: 7577925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A template-assembled model of the N-peptide helix bundle from HIV-1 Gp-41 with high affinity for C-peptide.
    Xu W; Taylor JW
    Chem Biol Drug Des; 2007 Oct; 70(4):319-28. PubMed ID: 17937777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of artificial salt bridge by Ile646Lys mutation in gp41 coiled-coil domain regulates 6-helical bundle formation.
    Zhao L; Hu ZW; Tong P; Chen YX; Zhao YF; Li YM
    Bioorg Med Chem Lett; 2013 May; 23(9):2727-32. PubMed ID: 23522564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hydrophobic pocket contributes to the structural stability of the N-terminal coiled coil of HIV gp41 but is not required for six-helix bundle formation.
    Dwyer JJ; Hasan A; Wilson KL; White JM; Matthews TJ; Delmedico MK
    Biochemistry; 2003 May; 42(17):4945-53. PubMed ID: 12718536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
    Gustchina E; Hummer G; Bewley CA; Clore GM
    J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of antiretroviral peptides corresponding to the C-terminal heptad repeat region (C-HR) of human immunodeficiency virus type 1 envelope glycoprotein gp41.
    Soonthornsata B; Tian YS; Utachee P; Sapsutthipas S; Isarangkura-na-Ayuthaya P; Auwanit W; Takagi T; Ikuta K; Sawanpanyalert P; Kawashita N; Kameoka M
    Virology; 2010 Sep; 405(1):157-64. PubMed ID: 20580393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of HIV-1 gp41-directed neutralizing and non-neutralizing fragment antibody binding domain (Fab) and single chain variable fragment (ScFv) antibodies to the ectodomain of gp41 in the pre-hairpin and six-helix bundle conformations.
    Louis JM; Aniana A; Lohith K; Sayer JM; Roche J; Bewley CA; Clore GM
    PLoS One; 2014; 9(8):e104683. PubMed ID: 25105806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-helix bundle completion in the distal C-terminal heptad repeat region of gp41 is required for efficient human immunodeficiency virus type 1 infection.
    Liu D; Wang H; Yamamoto M; Song J; Zhang R; Du Q; Kawaguchi Y; Inoue JI; Matsuda Z
    Retrovirology; 2018 Apr; 15(1):27. PubMed ID: 29609648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides.
    Malashkevich VN; Chan DC; Chutkowski CT; Kim PS
    Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9134-9. PubMed ID: 9689046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.
    Geng X; Liu Z; Yu D; Qin B; Zhu Y; Cui S; Chong H; He Y
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31277353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120.
    Liu S; Lu H; Niu J; Xu Y; Wu S; Jiang S
    J Biol Chem; 2005 Mar; 280(12):11259-73. PubMed ID: 15640162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buried polar interactions and conformational stability in the simian immunodeficiency virus (SIV) gp41 core.
    Ji H; Bracken C; Lu M
    Biochemistry; 2000 Feb; 39(4):676-85. PubMed ID: 10651632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target.
    Chan DC; Chutkowski CT; Kim PS
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15613-7. PubMed ID: 9861018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of residues in the coiled-coil domain of human immunodeficiency virus type 1 transmembrane protein gp41.
    Weng Y; Weiss CD
    J Virol; 1998 Dec; 72(12):9676-82. PubMed ID: 9811701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.